Combining our time-tested abilities in developed and emerging international markets

The Causeway International Opportunities strategy is a blend of Causeway’s best skills, combining our international value (bottom-up, fundamental, developed international markets, excluding the US) and emerging markets (quantitatively managed with a targeted tracking error of 5%) equity strategies. Tracking error is a measurement of dispersion from a benchmark index. Our quantitative research team developed a proprietary multi-factor model that measures the relative attractiveness of emerging markets, and guides the portfolio managers in tactically allocating between the developed and emerging portfolio segments.

Benchmark
MSCI ACWI ex US
Inception
June 30, 2007
Download Profile Sheet Download Flash Report Download Quarterly Review Risk Disclosures
Contact Us

Strategy overview

The portfolio managers discuss our International Opportunities strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
Quantitative Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Head of Quantitative Research
Quantitative Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Quantitative Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Quantitative Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 11.0%11.0%41.7%24.5%14.0%12.4%6.9%
Strategy (net) 10.9%10.9%41.1%24.0%13.6%12.0%6.5%
MSCI ACWI ex US 11.3%11.3%40.5%20.5%10.3%11.0%5.2%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 11.0%11.0%41.7%24.5%14.0%12.4%6.9%
Strategy (net) 10.9%10.9%41.1%24.0%13.6%12.0%6.5%
MSCI ACWI ex US 11.3%11.3%40.5%20.5%10.3%11.0%5.2%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 7.2%37.8%37.8%23.7%12.7%10.2%6.4%
Strategy (net) 7.1%37.2%37.2%23.1%12.2%9.7%6.0%
MSCI ACWI ex US 5.1%33.1%33.1%18.0%8.5%8.9%4.6%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 7.2%37.8%37.8%23.7%12.7%10.2%6.4%
Strategy (net) 7.1%37.2%37.2%23.1%12.2%9.7%6.0%
MSCI ACWI ex US 5.1%33.1%33.1%18.0%8.5%8.9%4.6%
Fund 20252024202320222021202020192018201720162015201420132012201120102009
Strategy (gross) 37.8%10.0%24.8%-11.1%8.0%6.5%23.4%-17.9%31.8%1.9%-4.0%-3.9%22.2%26.0%-11.7%15.5%48.8%
Strategy (net) 37.2%9.5%24.3%-11.4%7.6%6.1%22.9%-18.2%31.3%1.5%-4.4%-4.2%21.7%25.5%-12.0%15.1%48.4%
MSCI ACWI ex US 33.1%6.1%16.2%-15.6%8.3%11.1%22.1%-13.8%27.8%5.0%-5.3%-3.4%15.8%17.4%-13.3%11.6%42.1%
Table Header
Strategy (gross)
Strategy (net)
MSCI ACWI ex US
20252024202320222021202020192018201720162015201420132012201120102009
37.8%10.0%24.8%-11.1%8.0%6.5%23.4%-17.9%31.8%1.9%-4.0%-3.9%22.2%26.0%-11.7%15.5%48.8%
37.2%9.5%24.3%-11.4%7.6%6.1%22.9%-18.2%31.3%1.5%-4.4%-4.2%21.7%25.5%-12.0%15.1%48.4%
33.1%6.1%16.2%-15.6%8.3%11.1%22.1%-13.8%27.8%5.0%-5.3%-3.4%15.8%17.4%-13.3%11.6%42.1%

Portfolio (as of February 28, 2026)

Benchmark: MSCI ACWI ex US
Asset Allocation
Table Header Strategy
Stocks 98.8%
Cash 1.2%
Strategy Characteristics
Table Header Strategy Benchmark
No. of holdings 238 1970
Weighted avg. market cap (US $MM) $158,164 $171,285
FY2 price/earnings 11.8 14.3
Price/book value 1.9 2.4
Dividend yield (%) 2.5 2.4
TOP 10 HOLDINGS
Security Country Percent
Taiwan Semiconductor Manufacturing Co., Ltd. Taiwan 4.3
Kering SA France 3.3
Renesas Electronics Corp. Japan 2.9
AstraZeneca PLC United Kingdom 2.7
Alstom SA France 2.7
Samsung Electronics Co., Ltd. South Korea 2.3
Reckitt Benckiser Group Plc United Kingdom 1.9
SMC Corporation Japan 1.8
Roche Holding AG Switzerland 1.8
Barclays PLC United Kingdom 1.8

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Strategy Benchmark
Information Technology 20.7% 16.3%
Financials 18.0% 24.3%
Industrials 15.8% 15.2%
Consumer Discretionary 10.3% 8.9%
Health Care 10.0% 7.6%
Consumer Staples 6.8% 5.8%
Materials 6.3% 7.5%
Communication Services 4.9% 4.9%
Utilities 2.8% 3.2%
Energy 1.6% 4.6%
Real Estate 1.6% 1.6%
TOP 10 COUNTRIES
Country Strategy Benchmark
United Kingdom 19.6% 9.0%
France 13.4% 6.2%
Japan 8.5% 14.1%
China 8.4% 7.5%
Taiwan 8.0% 7.1%
South Korea 7.2% 5.7%
Germany 7.2% 5.6%
India 4.2% 4.0%
Netherlands 4.0% 3.2%
United States 2.3% 0.0%
Regional Allocation
  • Emerging Asia 28.7%
  • Euro 27.8%
  • Europe - Other 24.1%
  • Pacific 9.2%
  • North America 3.6%
  • Emerging Europe, Middle East, Africa 2.8%
  • Emerging Latin America 2.5%

Commentary (As of February 28, 2026)

Highlights

  • In February, developed international and emerging markets advanced while US equities declined, with value stocks outperforming growth across all three segments.
  • In the developed markets portion of the portfolio, we expect some of the portfolio’s most attractive opportunities to come from companies undergoing operational restructuring, where capable management teams can reaccelerate cash flow growth—often in currently unpopular areas such as industrials and consumer staples.
  • Strong earnings growth in the South Korean semiconductor sector, corporate governance reforms, and robust demand for goods in sectors with strategic importance such as defense, nuclear, power transformers, and shipbuilding have bolstered Korean stocks. We believe these tailwinds will persist in 2026.

Portfolio Attribution

The Portfolio underperformed the Index during the month. Portfolio holdings in the materials and pharmaceuticals & biotechnology industry groups, along with an overweight position in the software & services industry group, detracted from relative performance. Holdings in the semiconductors & semi equipment and health care equipment & services industry groups, as well as an overweight position in the technology hardware & equipment industry group, offset some of the underperformance compared to the Index. The largest detractor was global healthcare company, Novo Nordisk A/S (Denmark). Additional notable detractors included online services company, Tencent Holdings Ltd. (China), and information technology services and consulting company, Capgemini SE (France). The top contributor to return was electronic equipment manufacturer, Samsung Electronics Co., Ltd. (South Korea). Other notable contributors included integrated circuit manufacturer, Taiwan Semiconductor Manufacturing Co., Ltd. (Taiwan), and semiconductor company, Renesas Electronics Corp. (Japan).

Investment Outlook

In the absence of a prolonged geopolitical conflict in the Middle East, sustained earnings growth and abundant global liquidity could lift global equity market levels into 2026. While inflation progress remains uneven, G-7 central banks face mounting political and economic pressure to prioritize growth, suggesting an accommodative bias in monetary policy. Europe and Japan could attract increased global capital flows if deregulation efforts persist and Europe advances toward deeper single-market integration and institutional coordination. With conflict-induced spikes in market volatility, stock selection remains paramount. In the developed markets portion of the portfolio, we expect some of the portfolio’s most attractive opportunities to come from companies undergoing operational restructuring, where capable management teams can re-accelerate cash flow growth—often in currently unpopular areas such as industrials and consumer staples.

The US Federal Reserve recently lowered its target interest rate and announced quantitative easing measures to maintain supportive financial conditions. After strong performance in 2025, we believe the 2026 outlook for EM equities is supported by stable to falling US interest rates. From a country perspective, we are identifying attractive investment opportunities in South Korea. Strong earnings growth in the South Korean semiconductor sector, corporate governance reforms, and robust demand for goods in sectors with strategic importance such as defense, nuclear, power transformers, and shipbuilding have bolstered Korean stocks. We believe these tailwinds will persist in 2026. We were overweight South Korean stocks in the Portfolio as of year-end. We continue to monitor the fluid conflict in the Middle East and the Portfolio remains underweight stocks in the emerging Europe, Middle East, and Africa region due primarily to bottom-up considerations.

The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. The securities identified and described above do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Past performance does not guarantee future results. For a description of our performance attribution methodology, or to obtain a list showing every holding's contribution to the overall account's performance during the quarter, please contact our product manager, Kevin Moutes, at 310-231-6116 or [email protected].